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1. Introduction 
The ribosome-membrane junction of the rough 
endoplasmic reticulum of eukaryotic cells is now 
recognized to play a central role in the processing 
and transmembrane transport of secretory [l] as 
well as of some membrane proteins [2,3]. According 
to the signal hypothesis [ 1,4] nascent chains, des- 
tined for transmembrane translocation, recognize ER 
membranes via a sequence of amino acids (signal 
peptide) usually located at their N-terminus, thus 
establishing the ribosome-membrane junction. This 
junction is then most probably maintained not only 
by the nascent chain but also by a direct link between 
the ribosome and specific membrane binding sites 
[5,6]. Recently, two polypeptides, characteristic of 
rough microsomal membranes and termed ‘ribo- 
phorins’, have been implicated in the attachment of 
ribosomes to membranes [7]. 
Inhibitors of ribosome-membrane interaction 
would clearly be of great interest, both as a possible 
means to identify the membrane and/or ribosome 
sites involved in the binding reaction, as well as 
as tools to study the fate of secretory or membrane 
proteins synthesized by detached polysomes. The 
only such inhibitor reported so far is the triphenyl- 
methane dye, aurintricarboxylic acid (fig.1) [6], 
which has been shown to interfere with ribosome 
binding by attaching to membrane sites [8]. In 
addition, when added to a cell-free read-out amino 
acid incorporation system programmed by rough 
Abbreviations: ATA, aurintricarboxylic acid; ER, endo- 
plasmic reticulum; MDA, dimethyl 5,5-methylenedisakylic 
acid; POPOP, 1 ,4-bis [ 2-G-phenyloxasolyl)] benzene; PPO, 
2,Sdiphenyloxasole; TKM, 25 mM KCl, 50 mM Tris-HCI, 
(pH 7.5), 5 mM MgCl, 
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microsomes, this inhibitor was found to interfere 
with the cleavage of the signal peptide from a secre- 
tory preprotein, suggesting that direct attachment of 
ribosomes to membranes is necessary for transmem- 
brane translocation and processing of nascent chains 
[4]. However, the use of ATA in cell free amino acid 
incorporation systems is of limited value, because the 
drug has the disadvantage of being a good inhibitor 
of protein synthesis (of initiation as well as of elonga- 
tion, at higher concentrations [9]). Moreover, ATA 
inhibits numerous enzymes [lo]. We have therefore 
searched for other compounds, which might be more 
selective in their action. Here we report our results 
with methylenedisalicylic acid, a compound with two 
aromatic rings, whose condensation with salicylic acid 
yields ATA (fig.1). 
2. Materials and methods 
2.1. Materials 
The following chemicals were purchased from the 
indicated sources: [35S]methionine (spec. act. 700- 
Ho\ /CooH “O\ POOH 
0 
/ \ 
-\ 
_/ 
W 
nooc- ,-, 0 0 \ / 
HO' HO’ ‘CMlH 
a b ’ c 
Fig.1. Structural Iormulae of ATA (a), MDA (b) and salicylic 
acid (c). Reaction of salicylic acid with MDA in the presence 
of sodium nitrite and sulfuric acid yields ATA [ 19). 
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1100 Ci/mmol) and [5-3H]orotic acid (20-30 Ci/ 
mmol), the Radiochemical Centre (Amersham/Searle); 
micrococcal nuclease and all reagents for cell free 
amino acid incorporation, Sigma Chemical Co. (St 
Louis, MO); ATA, practical grade, Eastman 
(Rochester, NY); MDA, ICN Pharmaceut. (Plainview, 
NY); oligo (dT)-cellulose, Collab. Res. (Waltham, 
MA). All other reagents, of analytical grade, were 
purchased from Merck (Darmstadt). Centrifugations 
were carried out in Beckman centrifuges and radio- 
activity determinations in an Intertechnique SL-30 
scintillation counter. 1o-6 1o-5 1o-4 1o-3 
lnhtbltor concentration ( M ) 
2.2. Cell fractionation 
Rat liver rough microsomes were prepared as in 
[ 111, and the membrane-bound ribosomes were 
removed by the KCl-puromycin procedure [S ,6]. 
The resulting degranulated rough microsomes were 
stored in 66% glycerol at -2O’C. To label ribosomal 
RNA, rats were injected with [3H]orotic acid (100 
&i/100 g body wt) and sacrificed 2 days later. The 
3H-labeled membrane-bound ribosomes were 
detached from membranes and collected as in [6]. 
3H-Labeled ribosomes and degranulated rough micro- 
somes were used for the cell-free ribosome binding 
assay (see below). 
Fig.2. Inhibition of binding of ribosomes to degranulated 
rough microsomes by ATA and MDA. 100% binding repre- 
sents binding in controls without added inhibitor (=3000 
dpm). (o---o) ATA; (a-0) MDA. Bars represent stan- 
dard errors. For experimental details, see section 2. 
ubilized with Protosol (New England Nuclear) and 
counted in 10 ml toluene-PPO-POPOP. 
2.4. Cell free amino acid incorporation 
Free polyribosomes, used for cell free amino acid 
incorporation, were prepared as in [11,12]. The poly- 
somes were dissociated with SDS (IS%), the RNA 
extracted with phenollchlordform and mRNA 
purified by oligo(dT) affinity chromatography [ 141. 
Cell free amino acid incorporation, carried out in a 
rabbit reticulocyte lysate treated with micrococcal 
nuclease [ 151 and desalted by passage through a 
Sephadex G-50 column, was allowed to proceed at 
29’C. At the times indicated in fig.2,2.5 ~1 aliquots 
of the incubation mixtures were pipetted onto 
Whatman 3 MM filters, and the radioactivity incor- 
porated into protein was determined as in [ 161. 
2.3. Binding of 3H-labeled ribosomes to microsomal 
membranes 3. Results and discussion 
Ribosome-membrane binding was assayed essen- 
tially as in [6]. 3H-Labeled ribosomes (5000 dpm N 
15 pg RNA) and degranulated rough microsomes 
(-0.5 mg protein) were incubated for 30 min at 
0°C in 0.25 M sucrose-TKM in 0.120 ml final 
vol. in the absence or presence of inhibitors. The 
samples were then diluted with 9 vol. 2.2 M sucrose- 
TKM and overlaid with a discontinuous sucrose 
gradient consisting of 3.3 ml 1.6 M sucrose-TKM and 
1 ml 0.25 M sucrose-TKM. Membrane-attached 
ribosomes were separated from unattached ribosomes 
by centrifugation at 45 000 rev./min for 45 min in the 
SW 50.1 rotor. The membranes at the 1.6-0.25 M 
sucrose interface were collected and precipitated 
with trichloroacetic acid. The precipitates were sol- 
The inhibitory effects of MDA and ATA on the 
binding of ribosomes to microsomal membranes are 
compared in fig.2. The data with ATA are in agree- 
ment with those in [8]. As can be seen from the 
dose-response curves of the two compounds, MDA is 
-lo-fold less potent than ATA and strongly inhibits 
the binding reaction (85%) at 1 mM. At this concen- 
tration the compound was found to have essentially 
no effect on protein synthesis, when either rat liver 
free polyribosomes (fig.3a) or purified mRNA (fig.3b) 
were used for programming a nuclease-treated rabbit 
reticulocyte lysate. In the latter case, a slight reduc- 
tion in the rate of amino acid incorporation was 
observed, but the final amount of [35S]methionine 
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Fig.3. Effect of MDA and ATA on cell-free amino acid 
incorporation in a nuclease-treated reticulocyte lysate. 
(e-e) in (a,b) represents time course of incorporation 
in the lysate without added RNA. All other samples con- 
tained: (a) free polyribosomes (1.7A,, units/l 00 ~1 incuba- 
tion mixture); or (b) mRNA purified from free polyribo- 
somes (0.12 A 160 units/l00 1.t1 incubation mixture). (o-o) 
no inhibitors present; (n---A) + MDA 1 mM; (o-.-.-n) 
+ATA5OpM;(o-.-.-•)+ATA,O.SmM.Each 100~1 
reaction mixture contained 25 (a) or 50 (b) )Xi [%.]methio- 
nine. Radioactivity measurements were carried out on 2.5 ~1 
aliquots. 
incorporated was not appreciably different from that 
of the control sample (fig.3b). The lack of effect of 
MDA on protein synthesis is in agreement with 
[ 171. In contrast to MDA, concentrations of ATA 
which inhibit the binding of ribosomes to mem- 
branes, also affected protein synthesis. Thus, 50 PM 
ATA, which inhibits binding by 65%, was inhibitory 
in the system programmed with mRNA (tig.3b), 
but had no effect on polysomes (fig.3a). Since ATA 
at this low concentration is known to be inhibitory 
on chain initiation, but not on elongation [9], these 
data suggest hat the polysome-programmed system 
mainly terminates already partially-synthesized 
peptide chains, but does not initiate the synthesis of 
new ones. Higher concentrations of ATA (0.5 mM), 
which inhibit ribosome-membrane interaction by 
90%, are known also to block chain elongation [9], 
and were in fact found to be inhibitory on the 
polysome-programmed system (fig.3a). 
Our results show that MDA, 1 mM, can be used to 
effectively inhibit the attachment of ribosomes to 
membranes without interfering with protein synthesis. 
It is interesting that while all three salicylate rings of 
the ATA molecule are required for the inhibitory 
effect on protein synthesis, two rings are sufficient to 
interfere with ribosome-membrane interaction, 
although the two-ring compound, MDA, does have a 
lower potency than ATA. The one-ring compound, 
salicylic acid, whose condensation with MDA yields 
ATA, is ineffective as inhibitor both of protein syn- 
thesis [ 161 and of the binding reaction (unpublished). 
It must be mentioned that, since the commercial 
preparations of ATA and MDA are not pure, their 
inhibitory action on ribosome-membrane interaction 
might be due not to the compounds themselves, but 
to contaminants. A crude ATA preparation was 
fractionated into 8 components and the induction of 
nuclear swelling and dissociation of histones from 
DNA characteristic of crude ATA shown to be most 
probably due to a contaminant, formaurindicarbox- 
ylic acid [ 181. In view of this possibility, we purified 
the commercial preparation of MDA, as in [9]. The 
results obtained with the purified preparation were 
not different from those shown here. Thus, the inhib- 
itory effect on ribosome-membrane interaction 
seems to be due to MDA itself, unless the responsible 
contaminant is not removed by the purification 
procedure we employed. 
In conclusion, MDA promises to be a useful com- 
pound in studies aimed at elucidating the role of the 
ribosome-membrane junction in the processing and 
transmembrane transfer of secretory and membrane 
proteins. 
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